Time to reconsider moxifloxacin anti-anaerobic activity?

Luigi Principe; Gianfranco Sanson; Roberto Luzzati; Richard Aschbacher; Elisabetta Pagani; Francesco Luzzaro; Stefano Di Bella

doi:10.1080/1120009X.2022.2106637

Time to reconsider moxifloxacin anti-anaerobic activity?

Luigi Principe, Gianfranco Sanson, Roberto Luzzati, Richard Aschbacher, Elisabetta Pagani, Francesco Luzzaro, Stefano Di Bella

Krankenhaus Bozen

Publikation: Beitrag in Fachzeitschrift › Letter to the editor › Begutachtung

1 Quellenangabe (Web of Science)

Originalsprache	Englisch
Seiten (von - bis)	367-368
Seitenumfang	2
Fachzeitschrift	JOURNAL OF CHEMOTHERAPY
Jahrgang	35
Ausgabenummer	4
DOIs	https://doi.org/10.1080/1120009X.2022.2106637
Publikationsstatus	Veröffentlicht - Juli 2023

Zugriff auf Dokument

10.1080/1120009X.2022.2106637

Dieses zitieren

@article{b5da7b2a548a47d1bb4300c4bc30ca05,

title = "Time to reconsider moxifloxacin anti-anaerobic activity?",

keywords = "BACTEROIDES-FRAGILIS GROUP, ANTIMICROBIAL SUSCEPTIBILITY, Microbial Sensitivity Tests, Humans, Italy/epidemiology, Moxifloxacin/therapeutic use, Bacteria, Anaerobic, Drug Resistance, Bacterial, Anti-Bacterial Agents/pharmacology",

author = "Luigi Principe and Gianfranco Sanson and Roberto Luzzati and Richard Aschbacher and Elisabetta Pagani and Francesco Luzzaro and {Di Bella}, Stefano",

note = "Lehr-KH Bozen: Aschbacher, Pagani: Microbiology and Virology Laboratory, Health Service of Bolzano, Bolzano, Italy",

year = "2023",

month = jul,

doi = "10.1080/1120009X.2022.2106637",

language = "English",

volume = "35",

pages = "367--368",

journal = "JOURNAL OF CHEMOTHERAPY",